Sab Biotherapeutics, INC. (SABS) — 8-K Filings
All 8-K filings from Sab Biotherapeutics, INC.. Browse 1 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (1)
-
SAB Biotherapeutics Files 8-K with Exhibits
— Apr 22, 2026 Risk: low
SAB Biotherapeutics, Inc. filed an 8-K on April 22, 2026, primarily for Regulation FD Disclosure and Financial Statements/Exhibits. The filing includes various
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX